Regarding the cardiovascular system, AST-120 was found to delay atherosclerosis in a uremic atherosclerosis mouse model by preventing the reduction of soluble fms-like tyrosine kinase 1 (Flt1) (an antiangiogenic factor whose expression is usually suppressed by uremic toxins in vitro) [57]. This evidence concerns the gene FLT1 and atherosclerosis.